Harandi Hamid, Shafaati Maryam, Salehi Mohammadreza, Roozbahani Mohammad Mahdi, Mohammadi Keyhan, Akbarpour Samaneh, Rahimnia Ramin, Hassanpour Gholamreza, Rahmani Yasin, Seifi Arash
Research Center for Antibiotic Stewardship and Antimicrobial Resistance, Infectious Diseases Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Research Center for Antibiotic Stewardship and Antimicrobial Resistance, Infectious Diseases Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Artif Intell Med. 2025 Apr;162:103089. doi: 10.1016/j.artmed.2025.103089. Epub 2025 Feb 12.
Antimicrobial stewardship programs (ASPs) are essential in optimizing the use of antibiotics to address the global concern of antimicrobial resistance (AMR). Artificial intelligence (AI) and machine learning (ML) have emerged as promising tools for enhancing ASPs efficiency by improving antibiotic prescription accuracy, resistance prediction, and dosage optimization. This systematic review evaluated the application of AI-driven ASPs, focusing on their methodologies, outcomes, and challenges. We searched all of the databases in PubMed, Scopus, Web of Science, and Embase using keywords related to "AI" and "antibiotic." We only included studies that used AI and ML algorithms in ASPs, with the main criteria being empirical antibiotic selection, dose adjustment, and ASP adherence. There were no limits on time, setting, or language. Two authors independently screened studies for inclusion and assessed their risk of bias using the Newcastle Ottawa Scale (NOS) Assessment tool for observational studies. Implementation studies underscored AI's potential for improving antimicrobial stewardship programs. Two studies showed that logistic regression, boosted-tree models, and gradient-boosting machines could effectively describe the difference between patients who needed to change their antibiotic regimen and those who did not. Twenty-four studies have confirmed the role of machine learning in optimizing empirical antibiotic selection, predicting resistance, and enhancing therapy appropriateness, all of which have the potential to reduce mortality rates. Additionally, machine learning algorithms showed promise in optimizing antibiotic dosing, particularly for vancomycin. This systematic review aimed to highlight various AI models, their applications in ASPs, and the resulting impact on healthcare outcomes. Machine learning and AI models effectively enhance antibiotic stewardship by optimizing patient interventions, empirical antibiotic selection, resistance prediction, and dosing. However, it subtly draws attention to the differences between high-income countries (HICs) and low- and middle-income countries (LMICs), highlighting the structural difficulties that LMICs confront while simultaneously highlighting the progress made in HICs.
抗菌药物管理计划(ASPs)对于优化抗生素使用以应对全球对抗菌素耐药性(AMR)的关注至关重要。人工智能(AI)和机器学习(ML)已成为有前景的工具,可通过提高抗生素处方准确性、耐药性预测和剂量优化来提高抗菌药物管理计划的效率。本系统评价评估了人工智能驱动的抗菌药物管理计划的应用,重点关注其方法、结果和挑战。我们使用与“AI”和“抗生素”相关的关键词在PubMed、Scopus、Web of Science和Embase的所有数据库中进行了检索。我们仅纳入了在抗菌药物管理计划中使用AI和ML算法的研究,主要标准为经验性抗生素选择、剂量调整和抗菌药物管理计划依从性。对时间、设置或语言没有限制。两位作者独立筛选纳入研究,并使用用于观察性研究的纽卡斯尔渥太华量表(NOS)评估工具评估其偏倚风险。实施研究强调了AI在改善抗菌药物管理计划方面的潜力。两项研究表明,逻辑回归、增强树模型和梯度提升机器可以有效地描述需要改变抗生素治疗方案的患者与不需要改变的患者之间的差异。24项研究证实了机器学习在优化经验性抗生素选择、预测耐药性和提高治疗适宜性方面的作用,所有这些都有可能降低死亡率。此外,机器学习算法在优化抗生素剂量方面显示出前景,特别是对于万古霉素。本系统评价旨在突出各种AI模型、它们在抗菌药物管理计划中的应用以及对医疗保健结果的影响。机器学习和AI模型通过优化患者干预、经验性抗生素选择、耐药性预测和剂量来有效增强抗生素管理。然而,它也巧妙地提请人们注意高收入国家(HICs)与低收入和中等收入国家(LMICs)之间的差异,突出了低收入和中等收入国家面临的结构性困难,同时也突出了高收入国家取得的进展。